| - |
- |
Naïve to bDMARDs |
Switch from another pen to SB4 pen |
Switch from syringe to SB4 pen |
Other bDMARD therapy |
Total |
| Parameter |
Response |
(N=348) |
(N=96) |
(N=59) |
(N=9) |
(N=512) |
| Injection procedure |
Missing |
.. |
.. |
1 (-) |
.. |
1 (-) |
| ‘neutral’, ‘simple’ or ‘very simple’ |
334 (96%) |
93 (97%) |
57 (98%) |
9 (100%) |
493 (96%) |
| ‘difficult’ or ‘very difficult’ |
14 (4%) |
3 (3%) |
1 (2%) |
.. |
18 (4%) |
| Acoustic signal |
Missing |
2 (-) |
.. |
1 (-) |
.. |
3 (-) |
| ‘neutral’, ‘clear’, ‘very clear’ |
334 (97%) |
95 (99%) |
58 (100%) |
9 (100%) |
496 (97%) |
| ‘unclear’ or ‘very unclear’ |
12 (3%) |
1 (1%) |
.. |
.. |
13 (3%) |
| Indication of completed injection |
Missing |
1 (-) |
.. |
.. |
.. |
1 (-) |
| ‘neutral’, ‘clear’, ‘very clear’ |
335 (97%) |
92 (96%) |
56 (95%) |
9 (100%) |
492 (96%) |
| ‘unclear’ or ‘very unclear’ |
12 (3%) |
4 (4%) |
3 (5%) |
.. |
19 (4%) |
bDMARD = Biological Disease-Modifying Antirheumatic Drug.